A Lilly-funded phase 3b trial found Ebglyss cleared or nearly cleared hand and foot eczema in 53% of patients at 16 weeks, versus 27% on placebo.
Lilly’s Ebglyss Cleared or Nearly Cleared Hand and Foot Eczema in 53% of Patients Versus 27% on Placebo
by | Oct 2, 2026 | Uncategorized | 0 comments

Recent Comments